Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dWohCfbwoceOaYcdGSeM

  ADVERTISEMENT  
October 12, 2012
Sign upForwardArchiveAdvertise
Right Care. Right Now.

  Critical Care Update 
  • Palliative program in surgical ICU improves care, study says
    A program that included palliative care assessments for liver transplant patients admitted to a surgical ICU and meetings between clinicians and families helped to improve end-of-life care, according to a study in the Journal of Pain and Symptom Management. Researchers found the initiative helped care teams and families reach a consensus on goals sooner, including use of Do Not Resuscitate orders, which gave families more time with patients. MedWire News (U.K.) (10/9) LinkedInFacebookTwitterEmail this Story
  • Hospital collaboration on infection control boosts MRSA prevention
    Greater cooperation and coordination among hospitals on infection control measures reduced the prevalence of methicillin-resistant Staphylococcus aureus infections, a study found. The findings, based on data from 29 hospitals in Orange Country, Calif., appear in the journal Health Affairs. Nurse.com (10/9) LinkedInFacebookTwitterEmail this Story
  • Other News
  Medicine in the News 
  • Medicare/Medicaid shift not behind drop in hospital infections
    A 2008 Medicare and Medicaid policy that withholds payment for treating certain hospital-acquired infections is not responsible for declining infection rates in U.S. hospitals, according to a Harvard study in the New England Journal of Medicine. Researchers analyzed data from 400 acute care hospitals in 41 states and found that the downward trend preceded the policy. DoctorsLounge.com/HealthDay News (10/10) LinkedInFacebookTwitterEmail this Story
 
  • FDA could speed approval process for certain drugs
    Treatments with benefits that may outweigh their risks, including those that treat drug-resistant bacteria, infectious diseases and obesity, could get fast-tracked for approval. FDA Commissioner Dr. Margaret Hamburg said such drugs could be labeled for "special medical use," and could allow faster and smaller clinical trials so the drugs can be prescribed to those who need them most. Bloomberg Businessweek (10/11) LinkedInFacebookTwitterEmail this Story
  Trends and Technology 
  • FDA clears device to monitor patient respiration
    Respiratory Motion has secured 510(k) clearance from the FDA to market ExSpiron, a device that uses a monitor linked to an electrode pad to measure air flow in a patient's lungs. The device, slated for release in Texas and New England in January 2013, is expected to lower hospital costs by reducing complications tied to respiratory issues. Mass High Tech (Boston) (10/10) LinkedInFacebookTwitterEmail this Story
  • CDC: U.S. mortality rates dropped slightly in 2011
    The mortality rates for five out of the 15 main causes of death in the U.S. fell significantly from 2010 to 2011 and rates overall dipped slightly last year, but the average life expectancy remained at 78.7 years, according to a new CDC report. The rate of deaths from heart disease and cancer, which make up 47% of all U.S. deaths, dropped by 3% and 2.4%, respectively. The mortality rates declined for men and women. WebMD (10/10) LinkedInFacebookTwitterEmail this Story
  SmartQuote 
Children have never been very good at listening to their elders, but they have never failed to imitate them."
--James Baldwin,
American writer


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Sales Account Director:  Aaron Kern (202) 407-7866
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent Critical Care SmartBrief Issues:   Lead Editor:  Kathryn Doherty
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information